Session date: 
Wednesday, November 20, 2019 - 12:00pm to 1:00pm

Johanna Bendell, MD

Chief Development Officer

Director, Drug Development Unit Nashville

Sarah Cannon Research Institute

Tennessee Oncology

 

Dr. Bendell joined Sarah Cannon in 2008 and serves as Chief Development Officer. In her role, Dr. Bendell leads the development and expansion of physician, site and Pharma relationships across the Sarah Cannon network. Additionally, Dr. Bendell serves as Director of the GI Cancer Research Program, overseeing the clinical trial menu for GI cancers across the Sarah Cannon network. Her work in early drug development has helped guide first-in-man agents through proof-of-concept studies.

Dr. Bendell received her undergraduate and medical degrees from the University of Chicago in 1994 and 1998, respectively. She completed her internship and residency in the Department of Internal Medicine at Brigham and Women's Hospital in Boston, as well as a fellowship in adult oncology at Boston's Dana-Farber Cancer Institute. She is board certified in medical oncology. Additionally, she is an associate with Tennessee Oncology, PLLC.

Location: 
Bluemle Life Sciences Building
233 South 10th Street
Conference Room 101
Philadelphia, PA 19107
United States
Session Summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Attendance

Please login or register to take this course.